Olympus Corporation (OCPNF)
USD 15.5
(0.0%)
USD 15.5
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 242.56 Billion JPY | 69.12% |
| 2023 | 143.43 Billion JPY | 23.92% |
| 2022 | 115.74 Billion JPY | 100.55% |
| 2021 | 57.71 Billion JPY | -28.12% |
| 2020 | 80.28 Billion JPY | 885.49% |
| 2019 | 8.14 Billion JPY | -85.72% |
| 2018 | 57.06 Billion JPY | 33.38% |
| 2017 | 42.78 Billion JPY | -31.65% |
| 2016 | 62.59 Billion JPY | 816.42% |
| 2015 | -8.73 Billion JPY | -164.12% |
| 2014 | 13.62 Billion JPY | 69.91% |
| 2013 | 8.02 Billion JPY | 116.37% |
| 2012 | -48.98 Billion JPY | -1367.07% |
| 2011 | 3.86 Billion JPY | -91.91% |
| 2010 | 47.76 Billion JPY | 141.6% |
| 2009 | -114.81 Billion JPY | -298.05% |
| 2008 | 57.96 Billion JPY | 21.28% |
| 2007 | 47.79 Billion JPY | 67.34% |
| 2006 | 28.56 Billion JPY | 341.52% |
| 2005 | -11.82 Billion JPY | -135.24% |
| 2004 | 33.56 Billion JPY | 37.85% |
| 2003 | 24.34 Billion JPY | 136.87% |
| 2002 | 10.27 Billion JPY | -12.79% |
| 2001 | 11.78 Billion JPY | 533.71% |
| 2000 | 1.86 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 FY | 242.56 Billion JPY | 69.12% |
| 2024 Q1 | 240.56 Billion JPY | 583.12% |
| 2024 Q3 | 18.91 Billion JPY | 177.96% |
| 2024 Q2 | -24.26 Billion JPY | -110.09% |
| 2024 Q4 | 7.35 Billion JPY | -61.12% |
| 2023 Q2 | 41.97 Billion JPY | 68.85% |
| 2023 Q1 | 24.86 Billion JPY | -11.45% |
| 2023 FY | 143.43 Billion JPY | 23.92% |
| 2023 Q4 | 35.21 Billion JPY | -14.9% |
| 2023 Q3 | 41.38 Billion JPY | -1.42% |
| 2022 Q1 | 18.69 Billion JPY | 65.49% |
| 2022 Q3 | 25.27 Billion JPY | -42.18% |
| 2022 Q4 | 28.07 Billion JPY | 11.1% |
| 2022 FY | 115.74 Billion JPY | 100.55% |
| 2022 Q2 | 43.7 Billion JPY | 133.85% |
| 2021 Q2 | -19.96 Billion JPY | -629.75% |
| 2021 Q1 | -2.73 Billion JPY | 63.36% |
| 2021 Q4 | 11.29 Billion JPY | -53.57% |
| 2021 FY | 57.71 Billion JPY | -28.12% |
| 2021 Q3 | 24.32 Billion JPY | 221.84% |
| 2020 Q2 | 27.42 Billion JPY | 217.54% |
| 2020 FY | 80.28 Billion JPY | 885.49% |
| 2020 Q3 | 23.07 Billion JPY | -15.86% |
| 2020 Q4 | -7.46 Billion JPY | -132.36% |
| 2020 Q1 | 8.63 Billion JPY | 433.15% |
| 2019 Q2 | 11.19 Billion JPY | 167.07% |
| 2019 Q1 | -16.68 Billion JPY | -284.83% |
| 2019 Q4 | 1.62 Billion JPY | -86.52% |
| 2019 FY | 8.14 Billion JPY | -85.72% |
| 2019 Q3 | 12.02 Billion JPY | 7.42% |
| 2018 Q3 | 18.19 Billion JPY | -8.01% |
| 2018 FY | 57.06 Billion JPY | 33.38% |
| 2018 Q1 | 10.05 Billion JPY | -72.86% |
| 2018 Q4 | 9.02 Billion JPY | -50.4% |
| 2018 Q2 | 19.78 Billion JPY | 96.75% |
| 2017 Q3 | 15.85 Billion JPY | 8.36% |
| 2017 Q2 | 14.62 Billion JPY | 62.87% |
| 2017 FY | 42.78 Billion JPY | -31.65% |
| 2017 Q1 | 8.98 Billion JPY | -54.51% |
| 2017 Q4 | 37.04 Billion JPY | 133.73% |
| 2016 FY | 62.59 Billion JPY | 816.42% |
| 2016 Q2 | 19.07 Billion JPY | 14.0% |
| 2016 Q1 | 16.73 Billion JPY | 141.15% |
| 2016 Q4 | 19.74 Billion JPY | 180.4% |
| 2016 Q3 | 7.04 Billion JPY | -63.09% |
| 2015 FY | -8.73 Billion JPY | -164.12% |
| 2015 Q2 | 14.19 Billion JPY | 74.3% |
| 2015 Q3 | 9.59 Billion JPY | -32.38% |
| 2015 Q1 | 8.14 Billion JPY | 4.59% |
| 2015 Q4 | -40.66 Billion JPY | -523.79% |
| 2014 Q2 | -6.1 Billion JPY | -233.53% |
| 2014 Q3 | 13.78 Billion JPY | 325.66% |
| 2014 Q4 | 7.78 Billion JPY | -43.52% |
| 2014 FY | 13.62 Billion JPY | 69.91% |
| 2014 Q1 | -1.83 Billion JPY | -562.37% |
| 2013 Q2 | 12.47 Billion JPY | 379.87% |
| 2013 Q4 | 396 Million JPY | 201.28% |
| 2013 Q3 | -391 Million JPY | -103.14% |
| 2013 Q1 | -4.45 Billion JPY | 71.97% |
| 2013 FY | 8.02 Billion JPY | 116.37% |
| 2012 Q2 | -30.17 Billion JPY | -2020.52% |
| 2012 Q1 | -1.42 Billion JPY | -9.8% |
| 2012 Q3 | -756 Million JPY | 97.49% |
| 2012 Q4 | -15.9 Billion JPY | -2003.17% |
| 2012 FY | -48.98 Billion JPY | -1367.07% |
| 2011 Q1 | 1.5 Billion JPY | -63.19% |
| 2011 Q2 | 5.54 Billion JPY | 269.49% |
| 2011 FY | 3.86 Billion JPY | -91.91% |
| 2011 Q4 | -1.29 Billion JPY | -179.51% |
| 2011 Q3 | 1.63 Billion JPY | -70.61% |
| 2010 Q1 | 1.8 Billion JPY | 102.07% |
| 2010 FY | 47.76 Billion JPY | 141.6% |
| 2010 Q3 | 7.49 Billion JPY | -78.21% |
| 2010 Q4 | 4.07 Billion JPY | -45.57% |
| 2010 Q2 | 34.38 Billion JPY | 1804.04% |
| 2009 FY | -114.81 Billion JPY | -298.05% |
| 2009 Q4 | -87.13 Billion JPY | -178.63% |
| 2009 Q3 | -31.27 Billion JPY | -971.76% |
| 2009 Q2 | -2.91 Billion JPY | -144.75% |
| 2009 Q1 | 6.52 Billion JPY | 0.0% |
| 2008 FY | 57.96 Billion JPY | 21.28% |
| 2007 FY | 47.79 Billion JPY | 67.34% |
| 2006 FY | 28.56 Billion JPY | 341.52% |
| 2005 FY | -11.82 Billion JPY | -135.24% |
| 2004 FY | 33.56 Billion JPY | 37.85% |
| 2003 FY | 24.34 Billion JPY | 136.87% |
| 2002 FY | 10.27 Billion JPY | -12.79% |
| 2001 FY | 11.78 Billion JPY | 533.71% |
| 2000 FY | 1.86 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | 26169895.219% |
| Ansell Limited | 76.5 Million USD | -316979.739% |
| Ansell Limited | 76.5 Million USD | -316979.739% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 24.28 Million USD | -998928.015% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.63 Million USD | 14879231.516% |
| Psykey, Inc. | -1.32 Million USD | 18321472.921% |
| ConvaTec Group Plc | 130.3 Million USD | -186059.632% |
| ConvaTec Group Plc | 130.3 Million USD | -186059.632% |
| Encision Inc. | -691.78 Thousand USD | 35063985.64% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 171048890.291% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | 103498901.021% |
| Innovative MedTech Inc. | -7.93 Million USD | 3055511.854% |
| LifePoint, Inc. | -15.23 Million USD | 1592618.5% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | 3561485.993% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | 51174361.603% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -274.44 Thousand USD | 88383971.508% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | 52843499.531% |
| SmileDirectClub, Inc. | -86.4 Million USD | 280834.688% |
| Sector 10, Inc. | 7036.00 USD | -3447498478.738% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | -12016.753% |
| SheerVision, Inc. | -71.37 Thousand USD | 339842624.098% |
| United Health Products, Inc. | -2.62 Million USD | 9246814.116% |
| Vasamed, Inc. | -4.88 Million USD | 4962424.215% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | 10155819.129% |
| Yubo International Biotech Limited | -1.2 Million USD | 20133985.032% |